Rosetta Genomics' microRNA-based assay for Thyroid Cancer Highlighted in Poster Presentation at 84th Annual Meeting of the American Thyroid Association [Business Wire] - Rosetta Genomics Ltd. , a leading developer and provider of microRNA-based molecular diagnostics, announces that data in support of the Company’s microRNA-based assay 10/23/2014 07:00 AM
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.